Page last updated: 2024-10-29

imipramine and Hyperlipidemias

imipramine has been researched along with Hyperlipidemias in 1 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Hyperlipidemias: Conditions with excess LIPIDS in the blood.

Research Excerpts

ExcerptRelevanceReference
"Imipramine was highly bound to lipoproteins as well as to other plasma proteins."1.26Binding of imipramine to plasma proteins: effect of hyperlipoproteinemia. ( Chen, Z; Danon, A, 1979)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Danon, A1
Chen, Z1

Other Studies

1 other study available for imipramine and Hyperlipidemias

ArticleYear
Binding of imipramine to plasma proteins: effect of hyperlipoproteinemia.
    Clinical pharmacology and therapeutics, 1979, Volume: 25, Issue:3

    Topics: Blood Proteins; Chromatography, Gel; Humans; Hyperlipidemias; Imipramine; Protein Binding

1979